NCT05378620

Brief Summary

This study aims to culturally adapt an existing American Diabetes Association (ADA)-recognized diabetes self-management and support or DSMES (Diabetes Self Management Education Support) program (Project Dulce) and integrate an evidence-based text messaging program (Dulce Digital) for implementation in Filipino Americans (FAs) with type 2 diabetes mellitus (T2DM). Cultural adaptations aims to facilitate and enhance patient centered approaches and increase participant engagement by addressing barriers to DSMES unique to FAs, such as linguistic challenges, health literacy and numeracy, cultural beliefs and values, and technology access and use. In addition, this study aims to examine the effectiveness of the culturally and digitally adapted Project Dulce + Dulce Digital in improving diabetes knowledge, belief, attitudes, hemoglobin A1C (glycosylated hemoglobin), and self-management behaviors at baseline to 3 months and 6 months. The unprecedented increase of T2DM prevalence among racial and ethnic minority populations including FAs in recent decades demands for effective strategies to meet the needs in DSMES in this population. The outcomes of the current study will demonstrate that the culturally adapted Project Dulce and integration of Dulce Digital is effective in addressing the needs FAs, an underserved racial and ethnic minority group in high need of culturally appropriate DSMES.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 18, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

October 17, 2022

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2025

Completed
Last Updated

March 4, 2026

Status Verified

March 1, 2026

Enrollment Period

3.2 years

First QC Date

May 10, 2022

Last Update Submit

March 2, 2026

Conditions

Keywords

DiabetesSelf-ManagementEducation

Outcome Measures

Primary Outcomes (4)

  • Change from Baseline Diabetes Knowledge at 3 months

    Diabetes Knowledge Test (Fitzgerald, Funnell, Anderson, et al., 2016) is a 23-item measure of diabetes knowledge, with general questions related to symptoms, self-management (e.g., diet, exercise, foot care, blood glucose monitoring, insulin) , and complications (e.g., low and high blood sugar). Greater scores indicate greater diabetes knowledge.

    3 months

  • Change from Baseline Diabetes Knowledge at 6 months

    Diabetes Knowledge Test (Fitzgerald, Funnell, Anderson, et al., 2016) is a 23-item measure of diabetes knowledge, with general questions related to symptoms, self-management (e.g., diet, exercise, foot care, blood glucose monitoring, insulin) , and complications (e.g., low and high blood sugar). Greater scores indicate greater diabetes knowledge.

    6 months

  • Change in Baseline Self-Efficacy for Diabetes Scale at 3 months

    Stanford Self-Efficacy for Diabetes Scale (Lorig, Stewart, Ritter, et al., 1996) is comprised of 8 items that measure the confidence of a participant in performing self-care activities such as eating meals every 4 to 5 hours, following a healthful diet, exercising, and blood glucose monitoring. Response options range from 1=not at all confident to 10=totally confident, with higher scores indicating greater self-efficacy.

    3 months

  • Change in Baseline Self-Efficacy for Diabetes Scale at 6 months

    Stanford Self-Efficacy for Diabetes Scale (Lorig, Stewart, Ritter, et al., 1996) is comprised of 8 items that measure the confidence of a participant in performing self-care activities such as eating meals every 4 to 5 hours, following a healthful diet, exercising, and blood glucose monitoring. Response options range from 1=not at all confident to 10=totally confident, with higher scores indicating greater self-efficacy.

    6 months

Secondary Outcomes (8)

  • Change in Baseline Summary of Diabetes Self-Care Activities at 3 months

    3 months

  • Change in Baseline Summary of Diabetes Self-Care Activities at 6 months

    6 months

  • Change in Baseline Block Food Frequency Questionnaire at 3 months

    3 months

  • Change in Baseline Block Food Frequency Questionnaire at 6 months

    6 months

  • Change in Baseline International Physical Activity Questionnaire-Short Form at 3 months

    3 months

  • +3 more secondary outcomes

Other Outcomes (2)

  • Recruitment and Retention

    6 months

  • Participant Satisfaction

    6 months

Study Arms (1)

Project Dulce + Dulce Digital

OTHER

Patients will participate in a peer-led group diabetes self-management education and support program and receive ongoing support via text messages designed to improve knowledge, health beliefs, self-management behaviors and clinical outcomes.

Behavioral: Project Dulce + Dulce Digital

Interventions

Project Dulce will consist of a group diabetes self-management program consisting of a 5-week curriculum delivered by a peer educator in Tagalog. The curriculum provides new knowledge as well as skills and tools needed to adapt to a life with diabetes and change behaviors. The curriculum covers diabetes and its complication, the role of diet, exercise, and medication, and the importance of self-monitoring. It is presented over 5 weeks where participants will learn and practice self-management skills, and help one another address family, cultural, or health system barriers to managing your diabetes. Following the 5-week curriculum, participants will be enrolled in the digital texting platform, Dulce Digital, in which they will receive on-going support via text messages derived from the curriculum, medication reminders, and blood glucose monitoring prompts in Tagalog.

Project Dulce + Dulce Digital

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Self-identified Filipino
  • Diagnosed with T2DM
  • Registered at Scripps Health or San Ysidro Health (or willing to register)
  • HbA1c ≥7.5% and/or systolic blood pressure ≥ 140, and/or LDL-C ≥ 100 mg/dL within 90 days
  • Able to speak, read, write, and comprehend in English and Tagalog
  • Have access to a cell phone that can receive/send text messages throughout the study

You may not qualify if:

  • Severe illness precluding frequent visits to clinic
  • Liver function tests (ALT and AST) \> 3 times the upper limit of normal
  • Body mass index ≤ 23 kg/cm
  • History of malignancy, except subjects who have been disease-free for \>years, or whose only malignancy has been basal or squamous cell skin carcinoma
  • Creatinine \>3.5
  • History of drug or alcohol abuse within 12 months prior to enrollment
  • Not a permanent resident in the area
  • Current enrollee in Project Dulce
  • Blood donation of one pint or more within the past 30 days, or plasma donation within 7 days prior to screening
  • Anemia
  • Type 1 or gestational diabetes
  • Pregnant
  • Are currently participating in another diabetes-related study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

San Ysidro Health

National City, California, 91950, United States

Location

Scripps Whittier Diabetes Institute

San Diego, California, 92037, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Emily Rose N. San Diego, PhD

    Scripps Whittier Diabetes Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Corporate Vice President

Study Record Dates

First Submitted

May 10, 2022

First Posted

May 18, 2022

Study Start

October 17, 2022

Primary Completion

December 12, 2025

Study Completion

December 12, 2025

Last Updated

March 4, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations